Pryanka Thakur | Dengue | Young Scientist Award

Published on by Cell Biologist

Dr. Pryanka Thakur | Dengue | Young Scientist Award

Dr. Pryanka Thakur | Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh | India

Dr. Pryanka Thakur is a dedicated virologist and Project Research Scientist-I at PGIMER, Chandigarh, working in Professor Sunil Sethi’s laboratory. She earned her Ph.D. in Virology from PGIMER under the mentorship of Professor (Dr.) Radha Kanta Ratho, Dean of PGIMER. Her research revolves around molecular pathogenesis, particularly focusing on viral diseases such as Dengue, COVID-19, Hepatitis E, and emerging zoonotic threats. With numerous high-impact publications and presentations at national and international forums, Dr. Thakur has built a commendable academic and research portfolio. Her work contributes to a deeper understanding of viral mechanisms and their public health implications. She has received accolades like the Young Scientist Award and DST-SERB travel grant, reflecting her potential as a rising star in infectious disease research. Passionate about molecular diagnostics and disease pathogenesis, Dr. Thakur’s academic rigor and commitment position her as a promising candidate for the Research for Young Scientist Award.

Publication Profile: 

Orcid

Scopus

Education:

Dr. Pryanka Thakur completed her Ph.D. in Virology at the prestigious Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, from August 2018 to March 2024. Her thesis, titled “Role of inflammasome and autophagy in the pathogenesis of severity of Dengue fever,” was conducted under the supervision of Professor (Dr.) Radha Kanta Ratho, a leading authority in virology. Her doctoral work explored critical host-pathogen interactions, offering insights into mechanisms influencing disease severity. During this period, she honed her skills in molecular virology, diagnostics, and cellular biology. Her academic foundation is deeply rooted in translational and clinical virology, with particular emphasis on autophagy, inflammasomes, and immunological responses during viral infections. Through her rigorous training and extensive hands-on experience with cutting-edge lab techniques, she emerged as a well-rounded scientist with both technical expertise and conceptual depth in infectious disease research, specifically RNA viruses and M. tuberculosis.

Experience:

Dr. Pryanka Thakur currently serves as a Project Research Scientist-I in the Department of Medical Microbiology, PGIMER, Chandigarh, under the mentorship of Professor Sunil Sethi. Her research has primarily focused on virological and immunological responses to emerging and re-emerging infections. She has extensive experience in molecular biology, cell culture, diagnostics, and bioinformatics, contributing to major national and international research initiatives. During her Ph.D., she contributed significantly to studies on Dengue pathogenesis, SARS-CoV-2 evolution, and the intersection of autophagy and inflammasome activity. Her experience also includes collaboration with clinicians, epidemiologists, and diagnostic labs, showcasing her ability to work in interdisciplinary settings. Beyond lab work, she has actively participated in scientific writing, mentoring junior researchers, and presenting findings at forums like ECCMID and VIROCON. Her track record reflects a strong combination of leadership, innovation, and research integrity—making her a standout young investigator.

Awards and Honors:

Dr. Pryanka Thakur’s excellence in research has been recognized through prestigious accolades. In 2024, she was honored with the Young Scientist Award at the VIROCON 2024 conference held at DRDE, Gwalior, for her impactful Ph.D. research on Dengue virus pathogenesis. Additionally, she secured the highly competitive DST-SERB International Travel Grant to present her work at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark. These honors are a testament to the significance and quality of her research in infectious diseases. Her recognition on both national and international platforms demonstrates her rising reputation within the scientific community. These awards not only validate her current achievements but also underscore her potential for future contributions to global health challenges. Her work continues to resonate with experts in virology, public health, and molecular diagnostics—solidifying her status as a promising candidate for further research awards.

Research Focus:

Dr. Pryanka Thakur’s research is rooted in the pathogenesis, immunology, and molecular biology of emerging infectious diseases. Her Ph.D. research dissected the intricate roles of inflammasome activation and autophagy dysregulation in severe Dengue infections—paving the way for targeted therapies and better clinical outcomes. She also actively investigates RNA viruses, including SARS-CoV-2, Hepatitis E, Monkeypox, Nipah, and avian influenza, exploring their mutation patterns, immune evasion strategies, and pandemic potential. Her recent studies also delve into co-infections (e.g., Dengue and COVID-19 in pregnancy), and the reemergence of known pathogens in the post-pandemic era. Dr. Thakur maintains a special interest in molecular diagnostics, enabling early and accurate disease detection. Her contributions bridge laboratory science with clinical relevance, aiming to develop diagnostic tools and deepen our understanding of host-pathogen dynamics. This interdisciplinary approach positions her to make substantial contributions to the field of translational virology and public health microbiology.

Publications Top Notes: 

  1. Waves and variants of SARS-CoV-2: Understanding the causes and effect of the COVID-19 catastrophe – Infection, 2022.

  2. Viral Hepatitis E and Chronicity: A growing public health concern – Frontiers in Microbiology, 2020.

  3. Monkeypox virus in humans: A concern – Trespassing global boundaries – Int J Surg, 2022.

  4. Emergence of novel omicron hybrid variants: BA(x), XE, XD, XF – More than just alphabets – Int J Surg, 2022.

  5. Nipah Outbreak: Beginning of another pandemic in the era of COVID-19 and Zika? – Brain Behav Immun, 2021.

  6. Evolutionary dynamics of emergent SARS-CoV-2 variants: Just within a year – Immunome Research, 2021.

  7. Avian influenza revisited: Concerns and constraints – VirusDisease, 2022.

  8. Maternal and perinatal outcome in Dengue and COVID-19 co-infected pregnancies – Eur J Obstet Gynecol Reprod Biol, 2023.

  9. Post-COVID-19 era: Re-emergence of known and future (X) viral pathogens – Vacunas, 2024.

  10.  Paclitaxel production from endophytic Mucor circinelloides from Himalayan Taxus sp. – 3 Biotech, 2024.

Conclusion:

In conclusion, Dr. Pryanka Thakur is an exceptionally well-qualified candidate for the Research for Young Scientist Award. Her academic rigor, publication excellence, and strong interest in infectious disease pathogenesis make her a standout young researcher. She brings a unique blend of molecular insights and public health relevance to her work, making significant contributions to understanding emerging viral threats. With national recognition and international exposure already under her belt, she is on a clear upward trajectory in academic science. Supporting her at this stage through the Young Scientist Award would not only validate her past contributions but also empower her to lead future advancements in virology, diagnostics, and translational medical research. With minor enhancements in project independence and translational focus, Dr. Thakur is poised to become a future leader in infectious disease research, making her a deserving recipient of this award.

 

Shuxin Han | Molecular Mechanisms Signaling | Best Researcher Award

Published on by Cell Biologist

Dr. Shuxin Han | Molecular Mechanisms Signaling | Best Researcher Award

Dr. Shuxin Han | Xinjiang University | China

Dr. Shuxin Han is a distinguished molecular biologist and professor at Xinjiang University, widely recognized for his pioneering work in hepatobiliary and metabolic biology. With a research career spanning over two decades, Dr. Han has made major contributions to understanding how Kruppel-like factors, especially KLF15, regulate endobiotic and xenobiotic metabolism, impacting drug detoxification and metabolic disease mechanisms. He earned his Ph.D. from Kent State University and has held prestigious positions at Harvard Medical School and Case Western Reserve University. His groundbreaking studies have been published in high-impact journals like Nature Metabolism and Nature Communications, with several articles naming him as first or corresponding author. In addition to research, Dr. Han serves as a reviewer for top-tier journals in pharmacology, hepatology, and clinical science. He is also an academic leader, currently shaping the next generation of scientific talent and metabolic disease research in China.

Publication Profile: 

Scopus

Education:

Dr. Shuxin Han began his academic journey in Animal Sciences, earning a bachelor’s degree from Anhui Agricultural University (1994–1998). He advanced to a research assistant role at Peking University (1999–2000), where he deepened his scientific foundation. He then moved to the U.S. to pursue a Master’s in Biology at Temple University (2000–2003), followed by a Ph.D. in Molecular Biology from Kent State University (2004–2009), focusing on metabolic biology and gene regulation. This progression from general animal sciences to highly specialized molecular biology reflects a systematic and deep commitment to biomedical research. His strong academic preparation laid the foundation for a research career investigating how transcriptional regulators impact health and disease. Dr. Han’s training spans world-class institutions across both China and the United States, equipping him with diverse scientific perspectives and techniques.

Experience:

Dr. Shuxin Han has accumulated rich research and academic experience over nearly 30 years. His early career included a pivotal research assistant role at Peking University, followed by advanced training in biology and molecular biology at Temple and Kent State Universities. He completed prestigious postdoctoral training at Harvard Medical School (2009–2012) and Case Western Reserve University (2012–2015), where he later became a Senior Research Associate (2015–2019). He returned to China in 2019 as a Researcher at the University of Science and Technology of China First Affiliated Hospital, simultaneously engaging in academic duties at the university until 2023. Currently, he serves as a Professor and Academic Leader at Xinjiang University. Throughout his career, Dr. Han has built strong international collaborations, led research groups, and guided innovative projects in metabolic biology, demonstrating his leadership, research excellence, and academic mentorship capabilities.

Research Focus:

Dr. Shuxin Han’s research centers on the molecular regulation of metabolism, particularly focusing on the hepatobiliary and gastrointestinal systems. His work has elucidated the critical role of the Kruppel-like factor (KLF) family, especially KLF15, in controlling endobiotic and xenobiotic metabolism (EXM). These pathways govern how the body metabolizes both internal compounds and external substances like drugs. Dr. Han’s studies have shown that KLF15 acts as a master regulator, influencing drug resistance, liver injury, and metabolic homeostasis. His discoveries offer new insight into personalized medicine and treatment for metabolic disorders and drug-related toxicities. With numerous first-author and corresponding-author publications in journals such as Nature Metabolism, Nature Communications, and Drug Metabolism and Disposition, his work has significantly impacted both fundamental science and clinical applications. He is also active in peer-reviewing for top-tier journals and is recognized for his leadership in translational research.

Publications Top Notes:

  1. Unveiling KLF15 as the Key Regulator of Cyclosporine A Metabolism and Adverse Effects – Drug Metabolism and Disposition, 2025

  2. Distribution and Functional Significance of KLF15 in Mouse Cerebellum – Molecular Brain, 2025

  3. Personalized Statin Therapy: Targeting Metabolic Processes – Heliyon, 2025

  4. Current Status and New Directions for Hepatocellular Carcinoma Diagnosis – Liver Research, 2024

  5. KLF15-Cyp3a11 Axis Regulates Rifampicin-Induced Liver Injury – Drug Metabolism and Disposition, 2024

  6. Advancing Drug Delivery and Bioengineering in Liver Research – Bioengineering and Translational Medicine, 2024

  7. Advances in IL-7 Research on Tumor Therapy – Pharmaceuticals, 2024 (Co-author)

  8. Pathogenic Mechanisms in Alcoholic Liver Disease – Journal of Translational Medicine, 2023

  9. Beta-Hydroxybutyrate Effects on iPSC-Derived Cardiac Myocytes – Biomolecules, 2022

  10. Interactions Between Intestinal Flora and Bile Acids – International Journal of Molecular Sciences, 2022 (Corresponding author)

Conclusion:

In conclusion, Dr. Shuxin Han is a highly deserving candidate for the Best Researcher Award. His pioneering work on KLF15 and metabolic regulation has reshaped fundamental understanding in the field of hepatobiliary biology and pharmacology. His academic background, research productivity, international experience, and editorial service all reflect a well-rounded and impactful scientist. While there is room to increase clinical translation and international engagement, the depth, originality, and consistency of his research make him a strong contender for this recognition. Honoring Dr. Han with this award would acknowledge a career dedicated to scientific advancement with substantial implications for human health and drug therapy.

Kai Zhao | Signal Transduction Mechanisms | Cell Biology Research Award

Published on by Cell Biologist

Dr. Kai Zhao | Signal Transduction Mechanisms | Cell Biology Research Award

Dr. Kai Zhao | shandong first medical university | China

Kai Zhao is a dedicated biomedical scientist specializing in cell biology and translational medical research. Affiliated with the Central Hospital and Shandong First Medical University, Kai has focused on molecular mechanisms underlying diseases such as osteosarcoma and neurodegeneration. Their expertise includes mitophagy regulation, exosomal gene biomarkers, and multi-omics analyses, aiming to discover novel therapeutic targets. Kai has contributed significantly to understanding how cellular degradation pathways influence disease progression, with published work in prominent journals. They hold key roles in both clinical and research settings, bridging basic science and patient care. Their collaborative work and innovative approach have garnered attention in the biomedical community, underscoring their role as a rising leader in cell biology research.

Publication Profile: 

Orcid

Education:

Kai Zhao completed their foundational studies in medicine at a prestigious medical university in China, followed by advanced graduate training focusing on cellular and molecular biology. Their education provided a strong grounding in clinical medicine combined with rigorous laboratory research skills. They further specialized through postgraduate work that integrated molecular biology techniques and omics technologies, developing expertise in the mechanisms of disease at a cellular level. This multidisciplinary education enabled Kai to pursue research at the interface of clinical practice and experimental biology. They have also completed specialized training in bone biomechanics and metabolism, as well as spinal surgery, enhancing their ability to conduct translational research. Continuous professional development through workshops, conferences, and collaborative projects complements their formal education, keeping them updated on cutting-edge scientific advances.

Experience:

Kai Zhao has extensive experience working at the Central Hospital Affiliated with Shandong First Medical University, where they contribute both clinically and in research. Their experience includes investigating molecular pathways in osteosarcoma and neurodegenerative models using cell lines such as SH-SY5Y. Kai has led projects applying multi-omics data to identify exosomal gene biomarkers and therapeutic targets like mifepristone. Their role in the Spinal Surgery Department and Bone Biomechanics Laboratory has provided hands-on clinical insight, informing their research on bone and spinal disorders. Kai collaborates with multidisciplinary teams, combining clinical knowledge with molecular techniques. Their publication record reflects proficiency in advanced methodologies such as mitophagy analysis, molecular degradation pathways, and biomarker discovery. Kai also mentors junior researchers and participates in academic dissemination through publications and conferences, demonstrating leadership and a commitment to advancing cell biology research.

Research Focus:

Kai Zhao’s research centers on the molecular and cellular mechanisms driving disease, with an emphasis on mitophagy, exosomal biomarkers, and multi-omics analyses. They investigate how cellular quality control systems, such as the PINK1-mediated mitophagy pathway, contribute to neurodegenerative diseases and cancer progression, specifically osteosarcoma. By combining genomic, proteomic, and transcriptomic data, Kai aims to identify novel gene biomarkers within exosomes that can serve as diagnostic or therapeutic targets. One highlighted therapeutic candidate from their work is mifepristone, revealed through integrative multi-omics to be effective against osteosarcoma. Their research integrates cellular biology with clinical insights, particularly in bone metabolism and spinal diseases, aiming for translational impact. Overall, Kai’s focus is on uncovering how disruptions in cellular degradation and intercellular communication contribute to disease, leveraging multi-disciplinary approaches to develop targeted therapies.

Publication Top Notes:

    • Exosomal Gene Biomarkers in Osteosarcoma: Mifepristone as a Targeted Therapeutic Revealed by Multi‐Omics Analysis

    • IRGM promotes the PINK1-mediated mitophagy through the degradation of Mitofilin in SH-SY5Y cells

Conclusion:

Kai Zhao is a promising and capable researcher whose work directly contributes to cutting-edge cell biology, particularly in disease mechanisms. Their multi-omics and cellular degradation studies mark them as an excellent candidate for the Cell Biology Research Award.

Leandro Rodriguez-Viera | Molecular Mechanisms Signaling | Best Researcher Award

Published on by Cell Biologist

Dr. Leandro Rodriguez-Viera | Molecular Mechanisms Signaling | Best Researcher Award

Dr. Leandro Rodriguez-Viera | Universisdad de Cadiz | Spain

Dr. Leandro Rodríguez Viera is a marine biologist with dual Ph.D. degrees from the University of Havana (Cuba) and the University of Cádiz (Spain), specializing in digestive physiology and trophic ecology of marine organisms. With over 15 years of experience in biological and aquaculture research, he has significantly contributed to the understanding of nutrient metabolism and predation dynamics in marine ecosystems. His scientific trajectory is defined by interdisciplinary work combining enzymology, nutrition, and biodiversity. Dr. Rodríguez Viera has published extensively in high-impact journals and collaborates with research teams across Europe, Latin America, and the Caribbean. He is also a co-recipient of the prestigious Cuban Academy of Sciences National Prize. His dedication to marine biology is evident through his active role in identifying invasive species and documenting marine biodiversity. His contributions enhance conservation efforts, sustainable aquaculture, and the ecological management of tropical marine environments.

Publication Profile: 

Google Scholar

Scopus

Orcid

Education:

Dr. Leandro Rodríguez Viera’s educational journey began with a Bachelor in Biology from the University of Havana in 2008, followed by a Master’s degree in Marine Biology and Aquaculture in 2010 from the same institution. He earned a Ph.D. in Biological Sciences from the University of Havana in 2018, with research focused on digestive enzymology and metabolism in crustaceans. In parallel, he completed a second Ph.D., Cum Laude, from the University of Cádiz in Spain in 2017, strengthening his expertise in marine physiology and aquaculture. His academic training combines a strong foundation in molecular biology, comparative physiology, and aquatic animal nutrition, positioning him as a multidisciplinary expert in marine life sciences. This robust educational background underpins his successful career in scientific research and publications in diverse fields such as marine biodiversity, gelatinous zooplankton, and digestive physiology in aquatic species.

Experience:

Dr. Rodríguez Viera has over 15 years of research experience in marine biology, aquaculture, and marine ecology. He began his career focusing on the digestive physiology of the spiny lobster (Panulirus argus), contributing to fundamental knowledge and diet development for aquaculture. His career spans collaborative projects with institutions like the University of Cádiz, ICMAN-CSIC, and international teams across Europe and the Caribbean. Dr. Rodríguez Viera has led or co-led several projects on nutrient digestion, enzymatic adaptations, and jellyfish–predator interactions. He is an active contributor to taxonomic, ecological, and metabolic studies involving fish, crustaceans, cnidarians, and tunicates. As a prolific author, he has co-authored numerous peer-reviewed articles and guides. His interdisciplinary approach and regional focus on the Caribbean and Atlantic ecosystems make him a key scientific resource in marine trophic ecology, biodiversity documentation, and environmental monitoring programs.

Awards and Honors:

In 2019, Dr. Leandro Rodríguez Viera was honored with the National Prize of the Cuban Academy of Sciences for his contributions to digestive metabolism in the spiny lobster (Panulirus argus), which directly influenced aquaculture diet formulation. This prestigious award recognized his team’s work spanning universities in Cuba, Spain, and research institutes like ICMAN-CSIC. His earlier works also garnered significant academic citations, demonstrating influence in biochemical, nutritional, and ecological fields. Additionally, his publications in PLoS One, Journal of Experimental Biology, Aquaculture, and Marine Biology have earned wide recognition. Dr. Rodríguez Viera’s research continues to be integral to understanding digestive enzyme dynamics, invasive species spread, and marine food web interactions. His multidisciplinary reach, innovative methodologies, and cross-border collaborations underscore his impact, making him a strong candidate for international recognition and research awards.

Research Focus:

Dr. Rodríguez Viera’s research centers on marine trophic ecology, with a special focus on nutritional physiology, digestion, and gelatinous zooplankton interactions. His pioneering studies on Panulirus argus laid the groundwork for aquaculture diets tailored to digestive enzyme profiles. In recent years, he has explored predator–prey relationships among jellyfish, sea anemones, and fish, contributing to the knowledge of underexplored ecological roles in gelatinous food webs. He is also engaged in biodiversity documentation, especially of cnidarians and tunicates in Cuban and Caribbean waters. His integrative approach combines biochemical assays, molecular analysis, ecological fieldwork, and taxonomic identification. His ongoing projects address species invasions, climate-induced bleaching, and nutrient assimilation in marine organisms. This work supports sustainable marine resource use and enhances our understanding of tropical marine ecosystems, biodiversity threats, and aquaculture development.

Publications Top Notes: 

  1.  One-carbon nutrients and genistein as nutritional programming effectors in juvenile gilthead seabream – Aquaculture (2025)

  2.  Diversity of ctenophores from the Cuban Exclusive Economic Zone – Marine Biology Research (2025)

  3. Review of benthic cnidarians as underappreciated gelatinous predators – Marine Biology (2025)

  4.  Novel predation of Scyphozoans by sea anemone Condylactis gigantea – Diversity (2025)

  5.  First Atlantic record of genus Timoides in Cuban Caribbean waters – Thalassas (2025)

  6.  Ichthyofauna of Ensenada de la Siguanea: Guide to common mangrove and seagrass fishes – Rev. Invest. Mar. (2024)

  7.  First occurrence of invasive jellyfish Phyllorhiza punctata in the Dominican Republic – Bulletin of Marine Science (2024)

  8.  Opportunistic predation on hydromedusae by butterflyfish and crustaceans – Discover Oceans (2024)

  9.  Diversity of pelagic tunicates (Appendicularia & Thaliacea) from Cuba: A review – Marine Biodiversity (2024)

  10.  Asymmetrical bleaching of upside-down jellyfish Cassiopea in Cuba – Marine Biodiversity (2024)

Conclusion:

In conclusion, Dr. Leandro Rodríguez Viera is highly deserving of the Best Researcher Award based on his significant contributions to marine biology, digestive physiology, and aquaculture. His dual doctoral qualifications, cross-institutional collaborations, and publication impact reflect a strong and sustained commitment to scientific excellence. With a research trajectory that spans fundamental science to applied marine ecology, Dr. Rodríguez Viera exemplifies the qualities of an innovative and impactful researcher. With continued focus on academic leadership and broader outreach, he is well-positioned to further advance scientific frontiers and make lasting contributions to marine science and aquaculture development.

Alejandro Rojas | Immunology Cellular Interactions | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. Alejandro Rojas | Immunology Cellular Interactions | Best Researcher Award

Assist. Prof. Dr. Alejandro Rojas | Austral University of Chile | Germany

Dr. Alejandro Alfredo Rojas Fernández is a distinguished Chilean molecular biotechnologist and neuroscientist, currently serving as CEO of Berking Theranostics UG in Hamburg, Germany, and Assistant Professor at the Universidad Austral de Chile. With over two decades of research spanning neurodegeneration, immunology, and viral pathogenesis, Dr. Rojas-Fernández has emerged as a leading expert in molecular diagnostics and theranostics. His innovative work has significantly impacted global health, notably through his contributions to SARS-CoV-2 research and senolytic therapies. A dual academic and entrepreneur, he bridges fundamental science and clinical application, actively publishing in top-tier journals such as Nature Aging, Molecular Psychiatry, and Journal of Cell Biology. Fluent in interdisciplinary collaboration, his efforts have been internationally recognized with multiple honors. With a passion for translational science, Dr. Rojas-Fernández continues to inspire the next generation of biomedical innovators through mentorship and leadership in biotechnology and neuroscience.

Publication Profile:

Orcid

Education:

Dr. Alejandro Rojas-Fernández earned his PhD in Biology from the University of Konstanz, Germany (2006–2010), where his research focused on the regulation of Hdm2/HdmX-mediated ubiquitination and neddylation—mechanisms central to protein stability and cancer biology. Prior to his doctorate, he completed his engineering degree in Molecular Biotechnology (2004–2005) and his B.Sc. in Molecular Biotechnology Engineering (2000–2004) at the Faculty of Sciences, University of Chile—one of Latin America’s leading research institutions. His multidisciplinary education integrates molecular biology, neurobiology, immunology, and translational medicine, equipping him with the foundational and advanced tools to tackle complex biomedical challenges. Dr. Rojas-Fernández’s academic training has been marked by academic excellence and international mobility, enabling him to collaborate and lead research projects across Europe and Latin America.

Experience:

Dr. Rojas-Fernández brings over 20 years of experience in translational biomedical research, academia, and biotech innovation. As CEO of Berking Theranostics UG, he spearheads the development of personalized diagnostic platforms and therapeutics, with a focus on neurodegenerative and inflammatory diseases. In his role as Assistant Professor at Universidad Austral de Chile (20% appointment), he leads the Medical Biotechnology Laboratory within the Centre for Interdisciplinary Studies on the Nervous System (CISNe), contributing to scientific training and cutting-edge research. He previously trained and collaborated at institutions such as the University of Dundee, University of Queensland, and University of Constance, advancing molecular mechanisms of SUMOylation, proteostasis, inflammasome biology, and viral-host interactions. His interdisciplinary expertise allows him to translate complex cellular insights into tangible clinical applications, and his leadership has resulted in high-impact publications, product pipelines, and strategic biotech partnerships in Europe and Latin America.

Awards and Honors:

Dr. Rojas-Fernández has received multiple prestigious honors recognizing his innovative biomedical research. In February 2025, he was named “Innovator of the Month” by Hamburg Invest for groundbreaking biotech contributions in Germany. He was awarded the Medal of the City of Valdivia for his vital role in controlling the SARS-CoV-2 pandemic, one of the highest local honors in Chile. Additionally, he received the 2nd of October Medal for Science and Innovation, recognizing his scientific leadership in Chile’s Los Ríos region. These accolades underscore his impact on global public health, neurodegenerative research, and biotechnology entrepreneurship. His consistent recognition reflects a career dedicated to translational excellence, fostering international collaboration, and advancing science for the benefit of society. His scientific achievements continue to inspire innovation and interdisciplinary approaches within the global scientific community.

Research Focus:

Dr. Alejandro Rojas-Fernández’s research centers on cellular stress responses, ubiquitin/SUMO signaling, neurodegeneration, and host-pathogen interactions. A core focus is the molecular crosstalk between autophagy, protein quality control, and inflammasome activation in brain and immune cells. He has made significant advances in understanding the effects of SARS-CoV-2 on microglia, mechanisms of senescence in aging brains, and nanobody-based viral neutralization. His studies also explore the intersection of endoplasmic reticulum stress and neurodegenerative pathways, using high-content screening and proteomics to uncover therapeutic targets. He actively translates molecular insights into diagnostics and theranostic tools, positioning him at the forefront of personalized medicine. As CEO of a biotech startup, he is developing platforms that integrate biomarker discovery with AI for neuroinflammation profiling. His research bridges fundamental biology and clinical applications, promoting innovative therapies for Alzheimer’s, Parkinson’s, cancer, and viral infections.

Publications Top Notes: 

  1. Negative Modulation of Macroautophagy by Stabilized HERPUD1… – Front Cell Dev Biol, 2022

  2. SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia… – Mol Psychiatry, 2022

  3. The p97/VCP segregase is essential for arsenic-induced degradation of PML… – J Cell Biol, 2023

  4. Lack of Parkinsonian Pathology after Proteasome Inhibitor Injection… – Front Aging Neurosci, 2021

  5. NSPA modulates postsynaptic NMDAR stability… – BMC Biol, 2020

  6. Role of PSMD14 in Golgi-to-ER transport and APP processing – Cells, 2020

  7. WDR90 in NLRC4 inflammasome and Salmonella resistance – Dev Comp Immunol, 2019

  8. Proteomic identification of APC interaction partners – Mol Cancer Res, 2019

  9. DHX15 regulates CMTR1-dependent gene expression – Life Sci Alliance, 2018

  10.  Membrane ruffling by polarized stim1 and orai1 – Sci Reports, 2017

Conclusion:

Dr. Alejandro Alfredo Rojas Fernández stands out as a pioneering researcher who consistently delivers scientifically rigorous, socially impactful, and clinically relevant work. His career spans critical sectors—basic research, applied biotechnology, and public health—making him a model example of the translational scientist. With accolades from both European and Latin American institutions and a track record of high-impact publications, Dr. Rojas exemplifies what it means to be a globally relevant and community-driven scientist. His work during the COVID-19 pandemic, innovations in molecular neuroscience, and leadership in therapeutic biotechnology underscore his immense value to the global research community. In conclusion, he is not only a suitable but a highly deserving candidate for the Best Researcher Award.

Suping Gao | Plant Cell Biology | Best Researcher Award

Published on by Cell Biologist

Prof. Suping Gao | Plant Cell Biology | Best Researcher Award

Prof. Suping Gao | Sichuan Agricultural University – Chengdu Campus | China

Prof. Suping Gao is a leading academic in plant physiology, currently serving as a professor at Sichuan Agricultural University – Chengdu Campus, China. With a distinguished career focused on plant responses to abiotic stress, she has significantly advanced our understanding of how plants react to salt-induced anionic toxicity. As the corresponding author in multiple SCI-indexed publications, Prof. Gao has demonstrated excellence in research leadership, scientific writing, and experimental design. Her most recent work sheds light on how calcium salt anions affect photosynthesis and carbon mineralization in Ceratostigma willmottianum. Prof. Gao is an active contributor to high-impact journals and maintains an authoritative presence in international research platforms like ResearchGate. Her contributions are vital in developing strategies for improving plant resilience in changing environments. She is also known for her mentorship and collaborative projects, making her a strong contender for the Best Researcher Award.

Publication Profile: 

Orcid

Education:

Prof. Suping Gao’s academic journey has been rooted in plant sciences and agricultural biotechnology. She pursued her advanced studies in plant physiology and molecular biology, with a focus on plant-environment interactions. During her postgraduate and doctoral education, she specialized in the biochemical pathways and molecular mechanisms underlying abiotic stress responses, such as salt and drought. Her rigorous academic training enabled her to explore emerging research areas involving ion transport, anion toxicity, and carbon metabolism. She has also undergone specialized training in plant tissue culture and has conducted translational research applying laboratory insights to agricultural contexts. Prof. Gao’s academic background reflects a strong foundation in both theoretical concepts and practical techniques, making her well-prepared to lead impactful research and guide future scholars. Her education has laid the groundwork for her innovative exploration of the physiological and molecular mechanisms that enable plants to survive under extreme environmental conditions.

Experience:

Prof. Suping Gao brings a wealth of research and academic experience in the domain of plant abiotic stress. With over a decade of teaching and research at Sichuan Agricultural University, she has become an expert in plant physiological processes, especially under salt and calcium stress. She has successfully designed, implemented, and completed multiple plant stress-related research projects, some of which are published in prestigious journals like Plant Physiology and Plant and Soil. Prof. Gao has guided numerous postgraduate students and collaborated with interdisciplinary teams in the areas of plant nutrition, photosynthesis, and anion toxicity. Her experience extends to scientific consultancy and paper reviewing, adding further depth to her academic engagement. Recognized for her strategic research leadership, she has contributed not only as a scholar but also as a research organizer and project manager, often serving as the corresponding author and principal investigator on her studies.

Research Focus:

Prof. Suping Gao’s research focuses on the physiological and molecular mechanisms by which plants respond to abiotic stresses, particularly salt stress and calcium salt anion toxicity. Her work has revealed how different anions like chloride (Cl⁻) and nitrate (NO₃⁻) affect photosynthesis and mineral uptake in stress-resilient plants such as Ceratostigma willmottianum. She also investigates carbon sequestration through calcium carbonate formation in plants exposed to high-calcium environments. Her research aims to identify key metabolic and regulatory pathways that can be targeted for improving plant resistance and productivity under extreme environmental conditions. Prof. Gao utilizes a combination of plant physiology, molecular biology, and soil science in her investigations. Her studies hold significant agricultural relevance, especially in developing sustainable strategies for crop management in saline and alkaline soils. This makes her contributions pivotal for climate-resilient agriculture and global food security.

Publications Top Notes: 

  1. Ceratostigma willmottianum mineralizes atmospheric carbon dioxide into calcium carbonate in a high-calcium environment – Plant Physiology (2025)

  2. Calcium salt anion toxicity: Cl⁻ and NO₃⁻ differently inhibit Ceratostigma willmottianum photosynthesis – Plant and Soil (2025)

  3.  Sucrose signaling function on the formation and swelling of bulblets of Lilium sargentiae E.H. Wilson – Plant Cell, Tissue and Organ Culture (PCTOC) (2018)

Conclusion:

Prof. Suping Gao is an outstanding researcher in the field of plant stress physiology. Her impactful research, dedication to scientific advancement, and role as a leading academic make her a highly deserving candidate for the Best Researcher Award. Her future work is likely to continue contributing to both academic knowledge and agricultural sustainability.

 

 

Ying Xu | Reproductive Pharmacology | Women Researcher Award

Published on by Cell Biologist

Prof. Ying Xu | Reproductive Pharmacology | Women Researcher Award

Prof. Ying Xu | China Academy of Chinese Medical Sciences | China

Dr. Ying Xu is a distinguished Professor and Doctoral Supervisor at the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences. With extensive expertise in reproductive pharmacology and Traditional Chinese Medicine (TCM), she has made significant contributions to understanding female reproductive health through innovative TCM-based research. Her prolific academic career spans over two decades, with a focus on pharmacology, germline stem cells, and metabolomics. She has authored over 30 peer-reviewed publications and received multiple national research awards. Dr. Xu is also a dedicated mentor, serving as a master’s and doctoral advisor in prestigious institutions such as the Shanghai University of Traditional Chinese Medicine. Her work bridges traditional knowledge and modern pharmacological techniques to explore therapeutic interventions for conditions like infertility, ovarian dysfunction, and hormonal imbalances. Through international collaboration and pioneering research, Dr. Xu has become a leading voice in integrating Eastern and Western medicinal paradigms.

Publication Profile: 

Scopus

Education:

Dr. Ying Xu received her Ph.D. in Pharmacology of Traditional Chinese Medicine in 2010 from the Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine. Her doctoral work laid the foundation for her research in reproductive pharmacology using traditional formulations. In 2009, she participated in academic visitor studies at London Metropolitan University, expanding her global research perspectives. She earned her M.S. in Traditional Chinese Medicine from Heilongjiang University of Traditional Chinese Medicine in 2006, and a B.S. in Biological Pharmacy from Jilin University in 2000. Dr. Xu’s academic journey reflects a strong grounding in biomedical sciences with a specialized focus on the integration of pharmacology and traditional practices. Her education path is a testament to a progressive, interdisciplinary approach, building the expertise required to explore TCM through modern scientific lenses, particularly in female reproductive and endocrine health.

Professional Experience:

Dr. Xu has served as Professor and Doctoral Supervisor at the Institute of Chinese Materia Medica since 2020, contributing to high-level academic leadership and guiding doctoral research. She has been a Master’s Supervisor at Shanghai University of Traditional Chinese Medicine since 2018, fostering the next generation of TCM researchers. Between 2014 and 2019, she held the position of Associate Professor at the same institute, where she led several important projects in reproductive pharmacology. Her role spans teaching, research, mentorship, and international collaboration. With nearly two decades of professional academic engagement, Dr. Xu’s experience is marked by consistent research productivity, leadership in laboratory-based studies, and significant contributions to national projects on women’s reproductive health. Her multidisciplinary approach combines classical TCM theories with modern biochemical and pharmacological techniques, leading to discoveries in ovarian reserve function, stem cell therapies, and hormonal disorders.

Awards and Honors:

Dr. Ying Xu has received several prestigious awards recognizing her innovative research in Traditional Chinese Medicine. Notably, she was the second recipient on three significant awards from the China Academy of Chinese Medical Sciences and the Chinese Association of Integrative Medicine:

  1. Science and Technology Progress Award (Second Prize, 2016) – for research on compatibility in TCM based on the Fanghai treatment.

  2. Science and Technology Progress Award (Second Prize, 2016) – for pharmacodynamic characterization in anti-compatibility TCM practices.

  3. Science and Technology Progress Award (Third Prize, 2013) – for her work on the effect of Coptis chinensis on hemolytic jaundice in neonates.

These awards validate her impactful contributions in merging traditional therapeutic insights with contemporary medical applications. Her work in women’s reproductive pharmacology using TCM formulations continues to attract national recognition and supports advancements in female health and fertility.

Research Focus:

Dr. Xu’s research focuses on the pharmacological mechanisms of Traditional Chinese Medicine, with a specialized interest in female reproductive health, ovarian reserve, hormonal regulation, and germline stem cell therapies. Using advanced techniques like metabolomics, UPLC/Q-TOF-MS, and Notch signaling pathway analysis, her studies investigate how TCM formulations like Cistanches Herba, Semen Cuscutae, and QingYan Formula impact fertility, menopause, and ovarian function. Her research spans both in vivo (animal models) and in vitro (cell-based) studies, aiming to decode the biochemical pathways behind TCM efficacy. Dr. Xu is especially interested in kidney-Yang deficiency models, ovarian germline stem cells, and endocrine system modulation. Her interdisciplinary work bridges classical TCM theory with modern pharmaceutical sciences, paving the way for evidence-based TCM applications in gynecology and reproductive endocrinology. This holistic yet data-driven approach positions her at the forefront of innovative, woman-centered integrative health research.

Publications Top Notes: 

  1. Cistanche total glycoside capsule promotes sperm maturation and fertility via the NELL2 Lumicrine pathway (J Ethnopharmacol, 2025)

  2. Cistanche deserticola improves ovariectomy-induced osteoporosis via lipid metabolism regulation (J Ethnopharmacol, 2024)

  3. QingYan Formula alleviates perimenopausal syndrome via UPLC-Triple-TOF-MS-based metabolomics (J Pharm Biomed Anal, 2024)

  4. Cistanches Herba and reproductive outcomes: A comprehensive review (Phytomedicine, 2024)

  5. Semen Cuscutae flavonoids protect ovarian germline stem cells via Notch signaling (Stem Cell Rev Rep, 2024)

  6. Triptolide’s reproductive toxicity in arthritic female rats (Zhongguo Zhong Yao Za Zhi, 2024)

  7. Isolation and culture of ovarian germline stem cells in mice (Genomics Appl Biol, 2023)

  8. Cuscutae Semen + Tripterygium tablets on ovarian germline stem cells (Chin J Exp Trad Med Formulae, 2023)

  9. Toxicity of Tripterygium glycosides on ovarian stem cells in vitro (Zhongguo Zhong Yao Za Zhi, 2024)

  10.  “Property-efficiency-pharmacology-disease” relationship in estrogen-like TCM (Chin Tradit Herbal Drugs, 2023)

Conclusion:

Dr. Ying Xu embodies the essence of a leading female scientist who blends tradition with innovation to advance women’s health research. Her deep expertise in reproductive pharmacology of Traditional Chinese Medicine, combined with a strong track record of mentorship, publication, and national recognition, makes her an ideal candidate for the Research for Women Researcher Award. Despite some opportunities for broader international visibility, her contributions to female reproductive science through stem cell research, hormonal regulation studies, and herbal pharmacology are profound and deeply influential. Her work not only advances academic understanding but also addresses real health challenges faced by women, particularly through culturally relevant medical approaches. Recognizing Dr. Xu with this award would not only honor her scientific achievements but also encourage the integration of diverse medicinal philosophies in global women’s health research.

Farhad Ghorbani | Cancer Cell Biology | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. Farhad Ghorbani | Cancer Cell Biology | Best Researcher Award

Assist. Prof. Dr. Farhad Ghorbani | Shiraz University of Medical Sciences ,Shiraz,Iran | Iran

Dr. Farhad Ghorbani is an esteemed Assistant Professor of Oral and Maxillofacial Surgery at Shiraz University of Medical Sciences, Iran. With over two decades of clinical and academic experience, he has significantly contributed to the fields of oral pathology, trauma, and surgical interventions. A graduate of Kerman University of Medical Sciences, Dr. Ghorbani later specialized further at Shiraz University. His dedication to advancing clinical knowledge is reflected in over a dozen high-impact peer-reviewed publications, focusing on craniofacial abnormalities, surgical outcomes, and rare oral diseases. He is an active researcher with a Scopus Author ID and ORCID, consistently contributing to scientific journals like BMC Oral Health, Scientific Reports, and Maxillofacial Plastic and Reconstructive Surgery. His multidisciplinary collaborations have led to enhanced diagnostic techniques and patient outcomes. Dr. Ghorbani is recognized for both his innovative research and his commitment to medical education.

Publication Profile: 

Orcid

Google Scholar

Education:

Dr. Ghorbani began his medical journey at Kerman University of Medical Sciences, earning his professional doctorate in dentistry (1992–1998). Following years of clinical practice, he advanced his academic and surgical expertise by joining Shiraz University of Medical Sciences in 2013, where he underwent specialized training in Oral and Maxillofacial Surgery and served as an Assistant Professor during his educational tenure (2013–2018). His academic training focused on maxillofacial pathology, surgical techniques, and interdisciplinary diagnostics. The combination of strong foundational medical education and advanced surgical specialization has equipped him with both the theoretical depth and clinical acumen to lead impactful research. His training underlines a commitment to academic excellence and lifelong learning, which is further reflected in his scholarly contributions. Dr. Ghorbani’s educational background bridges foundational dental sciences with advanced surgical innovation.

Experience:

Since December 2018, Dr. Farhad Ghorbani has held the position of Assistant Professor of Oral and Maxillofacial Surgery at Shiraz University of Medical Sciences, Iran. His career blends clinical practice, research, and teaching. Over the years, he has led numerous studies exploring craniofacial morphology, surgical outcomes, dental trauma, and maxillofacial pathologies. He mentors postgraduate students and collaborates with interdisciplinary teams, enhancing diagnostic accuracy and surgical care. His work in both rural and urban settings has exposed him to a wide spectrum of maxillofacial cases, enriching his clinical insights. He actively contributes to improving surgical protocols and patient care standards. Dr. Ghorbani’s experience also includes academic publishing, peer reviews, and participation in scientific forums. He is recognized for his analytical approach and evidence-based practice. His long-standing affiliation with reputed institutions and research groups underscores his strong leadership in oral surgery and academic scholarship.

Research Focus:

Dr. Ghorbani’s primary research interests lie in oral pathology, craniofacial surgery, dentoalveolar trauma, and radiological diagnostics. His work often combines clinical case reports with retrospective analysis, offering insights into rare presentations such as parathyroid carcinoma-linked jaw tumors, and developmental anomalies like concha bullosa. A hallmark of his research is his ability to identify atypical symptoms and connect them with broader systemic conditions, ensuring early diagnosis and management. He has conducted fractal analysis studies to evaluate bone quality, and he explores patient-centered outcomes, such as satisfaction post-rhinoplasty and the psychological impacts of facial surgery. Additionally, his research evaluates the intersection of dental surgery with systemic health—evident in studies related to auditory changes post-orthognathic surgery or the implications of COVID-19 on dental care. Through evidence-based methods and innovative case analyses, Dr. Ghorbani has positioned himself as a thought leader in interdisciplinary oral and maxillofacial research.

Publications Top Notes:

  1. Brown tumors of both jaws as the initial manifestation of parathyroid carcinoma (BMC Oral Health, 2025)

  2. Distribution and laterality of concha bullosa across cranial skeletal types (Maxillofacial Plastic Surg, 2025)

  3. Calcifying Odontogenic Cyst in Posterior Maxilla: A Case Report (Journal of Dentistry Shiraz, 2025)

  4. Central giant cell granuloma mimicking fibro-osseous lesion and hemangioma (J Med Case Reports, 2024)

  5. Fractal CT analysis of mandibular condyles in class III malocclusion (Scientific Reports, 2023)

  6. Patient dissatisfaction following rhinoplasty: A 10-year Iranian study (Maxillofacial Plastic Surg, 2023)

  7. Correlation between impacted third molar and blood group (Int J of Dentistry, 2021)

  8. Effects of orthognathic surgery on auditory function (Maxillofacial Plastic Surg, 2021)

  9. Evaluation of alveolar fractures in trauma patients in Iran (BMC Oral Health, 2021)

  10. Anxiety in patients undergoing mandibular third molar extraction (J Oral Research & Review, 2020)

Conclusion:

In summary, Dr. Farhad Ghorbani embodies the qualities of a deeply committed, analytically skilled, and academically active oral and maxillofacial surgeon. His research is directly informed by his clinical experience, allowing him to bridge theory and practice effectively. His contributions have enriched the literature on oral pathology, surgical complications, facial aesthetics, and patient psychology following treatment interventions. While there are opportunities to expand the scope and scale of his work through more robust methodologies and international collaboration, his existing portfolio already reflects a high standard of academic and clinical integration. Given his track record, ongoing research productivity, and evident commitment to innovation and education, Dr. Ghorbani is a strong and deserving candidate for the Best Researcher Award. With continued growth in research leadership and expanded global outreach, he is poised to make an even greater impact in the years ahead.

Pratap Chand Mali | Zoology | Outstanding Scientist Award

Published on by Cell Biologist

Prof. Pratap Chand Mali | Zoology | Outstanding Scientist Award

Prof. Pratap Chand Mali | University of Rajasthan Jaipur | India

Dr. Pratap Chand Mali  is a seasoned Professor in the Department of Zoology at the University of Rajasthan, Jaipur. With over three decades of research experience in reproductive physiology, his scientific work centers on the antifertility effects of traditional medicinal plants. Known for his meticulous approach and ethical experimentation, Dr. Mali has contributed significantly to contraceptive research using animal models, particularly male albino rats. His pioneering studies explore plant-based alternatives to synthetic contraceptives, showcasing his deep interest in eco-friendly and indigenous healthcare solutions. Dr. Mali has actively participated in national and international scientific platforms, delivering invited talks and contributing to numerous peer-reviewed journals. A member of esteemed organizations like the Indian Science Congress Association and ISSRF, his academic and research journey reflects a commitment to innovation and excellence in biological sciences.

Publication Profile: 

Google Scholar

Orcid

Education:

Dr. Pratap Chand Mali holds an M.Sc. and a Ph.D. in Zoology from the University of Rajasthan. His doctoral thesis, titled “Antifertility Studies of Certain Xerophytic Plants in Male Albino Rats”, focused on exploring the contraceptive potential of native plant extracts on male reproductive systems. His specialization in reproductive biology and physiology has equipped him with a strong foundation in experimental design, pharmacological testing, and histopathological analysis. His research is notable for blending traditional botanical knowledge with modern pharmacology, aiming to develop safe, natural contraceptive agents. Throughout his academic career, Dr. Mali has demonstrated a keen interest in understanding plant bioactives and their systemic effects. He has trained several postgraduate and doctoral students and remains an inspiration in his field due to his in-depth academic training and practical experience.

Experience:

Dr. Pratap Chand Mali serves as a Professor in the Department of Zoology at the University of Rajasthan, with extensive teaching and research experience spanning over 30 years. His academic involvement includes undergraduate and postgraduate teaching, student mentorship, and curriculum development. He has supervised several Ph.D. scholars and has actively contributed to departmental research initiatives, particularly in reproductive toxicology and phytopharmacology. His research has been widely presented in national symposia and international conferences, including an invited speaker session in Dubai in 2021. Dr. Mali has been instrumental in bridging traditional plant medicine with reproductive physiology, establishing himself as a leading voice in antifertility research. His collaborative projects with Indian and international scientists reflect a global recognition of his expertise. His teaching philosophy emphasizes scientific curiosity and ethical research, making him a respected academic leader in his institution and the broader scientific community.

Awards and Honors:

Dr. Mali’s work has earned him several prestigious honors. He received the Asia-Pacific Council on Contraception (APCOC) Talents Encouragement Award in 2008 for his poster on the contraceptive activity of Withania somnifera at a conference held in Macau, China. In 2010, he was honored with the Best Citizen of India Award, acknowledging his contributions to science and education. He was also an Invited Speaker at the Pharmacology 2021 international conference in Dubai, where he delivered a lecture on traditional medicinal plants in modern pharmacopeia. A Life Member of the Indian Science Congress Association and the Indian Society for the Study of Reproduction and Fertility (ISSRF), his consistent academic contributions are highly valued. These awards and affiliations reflect his dedication to advancing knowledge in reproductive biology and his impactful role in both national and international scientific communities.

Research Focus:

Dr. Pratap Chand Mali’s research centers on the antifertility potential of traditional medicinal plants, particularly in male reproductive physiology. His experimental work involves phytochemical screening, hormonal analysis, and histological studies using male albino rats to assess the impact of various xerophytic plant extracts. His aim is to develop natural, reversible, and safe contraceptives by leveraging indigenous botanical knowledge. Dr. Mali’s investigations into plants such as Martynia annua, Euphorbia neriifolia, and Citrullus colocynthis have significantly contributed to understanding non-toxic alternatives to synthetic reproductive inhibitors. He is also interested in the mechanisms of spermatogenesis inhibition, lipid metabolism, and endocrine disruption by phytocompounds. His work is published in reputed journals like Journal of Ethnopharmacology and Pharmaceutical Biology, with several papers receiving international citations. Through his interdisciplinary research, he continues to address global fertility challenges using eco-conscious solutions grounded in Indian traditional medicine.

Publications Top Notes:

  1. Antifertility studies of root extract of Martynia annua Linn in male albino rats – Indian Science Congress, 1994

  2. Inhibition of spermatogenesis by Euphorbia neriifolia extract in male rats – ISSRF Symposium, 1994

  3. Antifertility study of Citrullus colocynthis fruit extract in male rats – ISSRF, 1994

  4. Antifertility effects of Echinops echinatus roots in male rats – J. Environ and Pollu., 1995

  5. Fertility regulation using Echinops echinatus root extract in rats – J. Phytol. Res., 1995

  6. Hypolipidemic effect of Convolvulus microphyllus in cholesterol-fed gerbils – J. Phytol. Res., 1995

  7. Antispermatogenic activity of Solanum xanthocarpum root extract in rats – J. Phytol. Res., 1996

  8. Antifertility effects of Euphorbia neriifolia root in male albino rats – Indian J. Environ. Sci., 1999

  9. Antispermatogenic effect of Citrullus colocynthis root extract – Pharmaceutical Biology, 2001

  10.  Effects of Martynia annua root extract on male rats – J. Ethnopharm., 2002

Conclusion:

Dr. Pratap Chand Mali is a deserving candidate for the Research for Outstanding Scientist Award based on the originality, depth, and societal relevance of his work. His pioneering studies on plant-based male contraceptives not only address a critical public health need but also contribute to sustainable and accessible healthcare innovation. His combination of academic leadership, consistent publication record, and international recognition through awards and invited talks makes him a valuable asset to the scientific community. With further strategic efforts to amplify his research’s reach and impact, he is well-positioned to continue making meaningful contributions to science and society. The award would serve as a well-earned recognition of his lifelong dedication to scientific inquiry and translational research in reproductive physiology.

 

 

 

John Carethers | DNA Repair | Best Researcher Award

Published on by Cell Biologist

Prof. John Carethers | DNA Repair | Best Researcher Award

Prof. John Carethers, UC San Diego, United States

Dr. John M. Carethers is a distinguished academic leader and physician-scientist in the field of gastroenterology and cancer genetics. Serving as Vice Chancellor for Health Sciences at the University of California San Diego, he also holds professorial appointments in both the School of Medicine and the Herbert Wertheim School of Public Health. His extensive contributions to colorectal cancer research, health disparities, and tumor biology have earned him national recognition. Dr. Carethers is renowned for his work on DNA mismatch repair mechanisms and their implications in cancer progression and treatment responsiveness. With a prolific publication record and influential roles in medicine and science policy, he stands as a model for translational research excellence. His commitment to mentorship and health equity further underscores his holistic impact on the field of medicine. Dr. Carethers continues to push scientific boundaries while advocating for inclusive healthcare solutions.

Publication Profile: 

Google Scholar

Scopus

Education:

Dr. Carethers completed his undergraduate education at Wayne State University, earning a B.S. in Biological Sciences with a minor in Chemistry (1981–1985). He graduated with distinction and was a recipient of the Michigan State Competitive Scholarship. He continued at Wayne State University School of Medicine, where he earned his M.D. with High Distinction in 1989. His academic performance was recognized with multiple honors including the Dean’s Academic Achievement Award and awards from the Black Medical Association. Dr. Carethers then completed an internship in Internal Medicine at Massachusetts General Hospital (1989–1990), a prestigious Harvard-affiliated institution, under the guidance of Chief of Medicine Dr. John T. Potts. His medical and research training provided the foundation for a career focused on gastrointestinal disorders, tumor genetics, and health disparities, particularly in colorectal cancer. His formative years reflect academic excellence and an early commitment to advancing medicine through both practice and research.

Professional Experience:

Dr. John M. Carethers currently serves as the Vice Chancellor for Health Sciences at the University of California San Diego. He is also a Distinguished Professor in the Department of Medicine and an Adjunct Professor in the School of Public Health. His career has spanned prestigious academic roles, including clinical and research leadership in gastroenterology, particularly focused on colorectal cancer. A physician-scientist, Dr. Carethers has served in roles that bridge bench science and clinical application, contributing significantly to translational medicine. His academic journey includes mentorship of emerging scientists, leadership in national research initiatives, and board participation in scientific organizations. His experience also encompasses major roles in cancer health disparities research, aiming to close gaps in outcomes across racial and socioeconomic lines. Dr. Carethers is a prolific researcher and thought leader whose experience enhances institutional vision, diversity, and health equity. His impactful career exemplifies a dedication to excellence in science and medicine.

Awards and Honors:

Dr. Carethers has been recognized with numerous academic and professional honors throughout his career. As an undergraduate, he received the Michigan State Competitive Scholarship and was inducted into the Golden Key National Honor Society. During medical school, he earned the Dean’s Academic Achievement Award and awards from the Black Medical Association in 1986 and 1987. Over time, he has been widely honored for his contributions to colorectal cancer research, healthcare leadership, and advocacy for health equity. His published work has been highly cited and influential in advancing our understanding of tumor genetics and mismatch repair. He has received numerous invitations for keynote talks and appointments to national research boards and committees. Dr. Carethers’s career has been marked by his commitment to mentoring, scholarly productivity, and advocacy, positioning him as a leader and role model in academic medicine. These honors underscore his national and global influence in health sciences.

Research Focus:

Dr. John M. Carethers’s research primarily focuses on colorectal cancer, particularly mechanisms of tumor progression, genetic and epigenetic alterations, and mismatch repair (MMR) deficiency. He has deeply explored how MMR status influences treatment responses, especially to chemotherapy agents like 5-fluorouracil. A key aspect of his work includes identifying biomarkers for cancer prognosis and understanding familial cancer syndromes, including Lynch syndrome and polyposis syndromes. His studies also delve into the molecular mechanisms underlying microsatellite instability (MSI) and its role in genomic instability. Importantly, Dr. Carethers is a leading voice in cancer health disparities, examining how social, economic, and biological factors impact outcomes among underrepresented populations. His research bridges basic molecular science with clinical applications, enabling personalized approaches to treatment and surveillance. Through his work, he contributes to reducing cancer burden and mortality while promoting health equity in vulnerable communities—making him a pioneer in both biomedical research and public health.

Publications Top Notes:

  1.  Experimental and clinical observations on frostbite

  2.  The epidemiology of methicillin-resistant Staphylococcus aureus in a burn center

  3.  Extraintestinal Manifestations of Crohn’s Disease

  4.  Human chromosome 3 corrects mismatch repair deficiency in colon tumor cells

  5.  Delayed gastric emptying after laparoscopic vagotomy

  6.  Mismatch repair and the G2 cell cycle checkpoint

  7. In vitro assay for screening hMLH1 and hMSH2 mutations

  8.  Massive secretory diarrhea and pseudo-obstruction in Crohn’s disease

  9.  Mismatch repair blocks clonal expansion after DNA damage

  10.  Localization of Bannayan-Riley-Ruvalcaba syndrome gene to chromosome 10q23

Conclusion:

In conclusion, Dr. John M. Carethers embodies the highest standards of research excellence, leadership, and societal impact. His contributions to colorectal cancer genetics, DNA mismatch repair research, and cancer health disparities are not only scientifically rigorous but also clinically transformative. As a widely respected physician-scientist, educator, and health equity advocate, he represents the ideal blend of scholarly productivity and service to humanity. Despite minor opportunities for expanding the global and technological dimensions of his work, Dr. Carethers’s achievements place him in the top tier of biomedical researchers. His continued dedication to both advancing science and closing health outcome gaps aligns perfectly with the spirit of the Best Researcher Award. He is not only deserving of this honor but also serves as an inspiring model for current and future generations of researchers.